Protein Protocols Protein Protocols

Single-Chain Antibodies 1045
16. Hockney, R. C. (1994) Recent developments in heterologous protein production in
Escherichia coli. Trends Biotechnol. 12, 456–463.
17. Knappik, A. and Plückthun, A. (1995) Engineered turns of a recombinant antibody
improve its in vivo folding. Protein Eng. 8, 81–89.
18. Kipriyanov, S. M., Moldenhauer, G., Martin, A. C. R., Kupriyanova, O. A., and Little, M.
(1997) Two amino acid mutations in an anti-human CD3 single-chain Fv antibody fragment
that affect the yield on bacterial secretion but not the affinity. Protein Eng. 10, 445–453.
19. Duenas, M., Vazquez, J., Ayala, M., Soderlind, E., Ohlin, M., Perez, L., et al. (1994) Intraand
extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial
strains and pathway engineering using GroES/L chaperonins. BioTechniques 16, 476–477.
20. Knappik, A., Krebber, C., and Plückthun, A. (1993) The effect of folding catalysts on the
in vivo folding process of different antibody fragments expressed in Escherichia coli. Biotechnology
11, 77–83.
21. Bothmann, H. and Plückthun, A. (2000) The periplasmic Escherichia coli peptidylprolyl
cis,trans-isomerase FkpA. I. Increased functional expression of antibody fragments with
and without cis-prolines. J. Biol. Chem. 275, 17,100–17,105.
22. Bothmann, H. and Plückthun, A. (1998) Selection for a periplasmic factor improving
phage display and functional periplasmic expression. Nat. Biotechnol. 16, 376–380.
23. Skerra, A. and Plückthun, A. (1991) Secretion and in vivo folding of the Fab fragment
of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines.
Protein Eng. 4, 971–979.
24. Sawyer, J. R., Schlom, J., and Kashmiri, S. V. S. (1994) The effect of induction conditions
on production of a soluble anti-tumor sFv in Escherichia coli. Protein Eng. 7, 1401–1406.
25. Kipriyanov, S. M., Moldenhauer, G., and Little, M. (1997) High level production of
soluble single-chain antibodies in small-scale Escherichia coli cultures. J. Immunol.
Meth. 200, 69–77.
26. Kipriyanov, S. M. and Little, M. (1997) Affinity purification of tagged recombinant proteins
using immobilized single-chain Fv fragments. Analyt. Biochem. 244, 189–191.
27. Arnold-Schild, D., Kleist, C., Welschof, M., Opelz, G., Rammensee, H. G., Schild, H., and
Terness, P. (2000) One-step single-chain Fv recombinant antibody-based purification of
gp96 for vaccine development. Cancer Res. 60, 4175–4178.
28. Casey, J. L., Keep, P. A., Chester, K. A., Robson, L., Hawkins, R. E., and Begent, R. H.
(1995) Purification of bacterially expressed single-chain Fv antibodies for clinical applications
using metal chelate chromatography. J. Immunol. Meth. 179, 105–116.
29. Kipriyanov, S. M., Moldenhauer, G., Strauss, G., and Little, M. (1998) Bispecific CD3 × CD19
diabody for T cell-mediated lysis of malignant human B cells. Int. J. Cancer 77, 763–772.
30. Müller, K. M., Arndt, K. M., Bauer, K., and Plückthun, A. (1998) Tandem immobilized
metal-ion affinity chromatography/immunoaffinity purification of His-tagged proteins—
evaluation of two anti-His-tag monoclonal antibodies. Analyt. Biochem. 259, 54–61.
31. Schulze, R. A., Kontermann, R. E., Queitsch, I., Dübel, S., and Bautz, E. K. (1994)
Thiophilic adsorption chromatography of recombinant single-chain antibody fragments.
Analyt. Biochem. 220, 212–214.
32. Müller, K. M., Arndt, K. M., and Plückthun, A. (1998) A dimeric bispecific miniantibody
combines two specificities with avidity. FEBS Lett. 432, 45–49.
33. Maurer, R., Meyer, B., and Ptashne, M. (1980) Gene regulation at the right operator (O R)
bacteriophage λ. I. O R3 and autogenous negative control by repressor. J. Mol. Biol. 139,
147–161.
34. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.